A malaria vaccine that elicits in
humans antibodies able to killPlasmodium falciparum.
Not exact matches
Weiner, Elliott and colleagues studied the DNA sequences for two
human monoclonal
antibodies — one
able to broadly target influenza A viruses and one
able to broadly target influenza B viruses — with collaborators at Inovio and MedImmune.
«We have followed a less potent neutralizing lineage in this particular individual before, but now we have found a far more potent
antibody and have been
able to study its development over six years,» said first author Mattia Bonsignori, M.D., of the Duke
Human Vaccine Institute.
Professor Hayday added: «This is very significant because
antibodies make up one of the largest sectors of the pharmaceutical market, and one of the great quests in the pharmaceutical industry is to be
able to routinely generate
antibodies against
human proteins implicated in diseases.
To date, no immunization of
humans or animals has elicited broadly neutralizing sera
able to prevent HIV - 1 transmission; however, elicitation of broad and potent heavy chain only
antibodies (HCAb) has previously been reported in llamas.
However, because they don't engage the immune system the way
antibodies do, and because of questions of stability and potency, it was not clear whether they would be
able to prevent infection in animals, or eventually, in
humans.
The mouse TPO receptor is almost identical to
human TPO receptor, so Zhang was
able to test his
antibody agonist in mice.
Using blood collected from elderly persons aged up to one hundred and demonstrating no cognitive impairment, the researchers isolated precisely those immune cells whose
antibodies are
able to identify toxic beta - amyloid plaques but not the amyloid precursor protein that is present throughout the
human body and that presumably plays an important role in the growth of nerve cells.
Researchers have now been
able to show that Aducanumab, a
human monoclonal
antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques.
Human monoclonal
antibodies induced during Ebola infection are
able to neutralize related viral species, scientists show.